These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9838474)

  • 41. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract]   [Full Text] [Related]  

  • 42. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
    Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ
    Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215
    [No Abstract]   [Full Text] [Related]  

  • 43. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
    Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 46. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
    J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic rejection in pediatric liver transplantation.
    Cho JH; Bhatnagar V; Andreani P; Muiesan P; Portmann B; Baker A; Mieli-Vergani G; Gibbs P; Rela M; Heaton ND
    Transplant Proc; 1997; 29(1-2):452-3. PubMed ID: 9123078
    [No Abstract]   [Full Text] [Related]  

  • 50. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical impact of Neoral in heart transplantation.
    Aziz T; el-Gamel A; Keevil B; Martyszczuk R; Campbell C; Rahman A; Deiraniya A; Yonan N
    Transplant Proc; 1998 Jun; 30(4):1152-3. PubMed ID: 9636466
    [No Abstract]   [Full Text] [Related]  

  • 54. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 55. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination drug therapies for immunosuppression in transplantation.
    McWhinnie DL; Morris PJ
    Ann Acad Med Singap; 1991 Jul; 20(4):498-502. PubMed ID: 1724724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tacrolimus in heart transplant recipients: an overview.
    Patel JK; Kobashigawa JA
    BioDrugs; 2007; 21(3):139-43. PubMed ID: 17516709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 60. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.